Precision Optics Corporation, Inc. (POCI)
NASDAQ: POCI · Real-Time Price · USD
4.750
+0.140 (3.16%)
Nov 7, 2024, 11:24 AM EST - Market open
POCI Revenue
In the fiscal year ending June 30, 2024, Precision Optics Corporation had annual revenue of $19.10M, down -9.22%. Precision Optics Corporation had revenue of $4.72M in the quarter ending June 30, 2024, a decrease of -6.13%.
Revenue (ttm)
$19.10M
Revenue Growth
-9.22%
P/S Ratio
1.46
Revenue / Employee
$227,433
Employees
84
Market Cap
30.16M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Jun 30, 2024 | 19.10M | -1.94M | -9.22% |
Jun 30, 2023 | 21.04M | 5.37M | 34.23% |
Jun 30, 2022 | 15.68M | 5.00M | 46.87% |
Jun 30, 2021 | 10.67M | 751.55K | 7.57% |
Jun 30, 2020 | 9.92M | 3.12M | 45.84% |
Jun 30, 2019 | Pro | Pro | Pro |
Jun 30, 2018 | Pro | Pro | Pro |
Jun 30, 2017 | Pro | Pro | Pro |
Jun 30, 2016 | Pro | Pro | Pro |
Jun 30, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Equillium | 42.62M |
Bionano Genomics | 36.58M |
Spectral AI | 22.53M |
Tonix Pharmaceuticals Holding | 12.46M |
BioXcel Therapeutics | 2.40M |
OneMedNet | 1.02M |
Femasys | 950.10K |
CytoMed Therapeutics | 330.25K |
POCI News
- 5 weeks ago - Precision Optics Corporation, Inc. (POCI) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 5 weeks ago - Precision Optics Reports Fourth Quarter and Fiscal Year 2024 Financial Results - GlobeNewsWire
- 6 weeks ago - Precision Optics Corporation Schedules Fourth Quarter and Fiscal Year 2024 Conference Call for Monday, September 30, 2024 - GlobeNewsWire
- 7 weeks ago - Ophthalmic Lens and Precision Optics Manufacturing Machines Industry Research 2023-2030: Increasing Focus on Precision and Customization Sustains Growth in High-Performance Optics - GlobeNewsWire
- 4 months ago - Precision Optics Appoints Clay Schwabe as VP of Sales and Marketing - GlobeNewsWire
- 6 months ago - Precision Optics to Participate in the Lytham Partners Spring 2024 Investor Conference on May 30, 2024 - GlobeNewsWire
- 6 months ago - Precision Optics Corporation, Inc. (POCI) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 6 months ago - Precision Optics Reports Third Quarter Fiscal Year 2024 Financial Results - GlobeNewsWire